Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2023

Dec 18, 2023

65058_rns_2023-12-18_6b268ed3-09c1-434d-83bd-54198e94fc1d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Sally Evans
Date of last notice 6 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest. As shown
Date of change 13 December 2023
No. of securities held prior tochange 34,882 Ordinary Shares*Sally Evans15,000 Ordinary SharesRBC Investor Services AustraliaNominees Pty Ltd<Evans A/C>* Shares are subject to a holding lock as “Restricted Securities” under the NEDShare Plan.
Class NED Share Rights
Number acquired 32,900
Number disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation $50,000 cash equivalent using the volume weighted average priceof Ordinary Shares over the five business days immediatelyfollowing the Healius Limited Annual General Meeting on 28November 2023, being $1.52 per share
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held afterchange *Sally Evans
of securitienge s held after 34,882 Ordinary Shares RBC Investor Services Australia
15,000 Ordinary SharesNominees Pty Ltd<Evans A/C>
32,900 NED Share Rights
* Shares are subject to a holding lock as “Restricted Securities” under the NEDShare Plan.
Nature of changeExample:on-markettrade,off-markettrade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back Issue of securities under the NED Share Plan

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Mary Weaver Company Secretary Date: 19 December 2023

  • See chapter 19 for defined terms.

Appendix 3Y Page 2